Dermatology Medical News about Scleromyxoedema

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Vincristine, Idarubicin, Dexamethasone and Thalidomide in Scleromyxoedema
Acta Dermato-Venereologica, 10/29/09

Laimer M et al. – The article discusses current proposed therapeutic strategies and reports the case of a 64–year– ld male patient with progressive scleromyxoedema associated with IgG– paraproteinaemia in whom monthly administrations of vincristine, idarubicin and dexamethasone in addition to daily oral thalidomide led to clinical and laboratory remission within 12 weeks.

<< Previous
Health expenditure and income in the United States

Next >>
Extraction of skin lesion texture features based on independent...